These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36660176)
1. lncRNA DLX6-AS1 Promotes Myocardial Ischemia-Reperfusion Injury through Mediating the miR-204-5p/FBXW7 Axis. Wang F; Wu Y Mediators Inflamm; 2023; 2023():9380398. PubMed ID: 36660176 [TBL] [Abstract][Full Text] [Related]
2. LncRNA AZIN1-AS1 ameliorates myocardial ischemia-reperfusion injury by targeting miR-6838-5p/WNT3A axis to activate Wnt-β/catenin signaling pathway. Zhang G; Ding L; Sun G; Liu Z; Ou W; Wang B; Sun Y In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):54-68. PubMed ID: 35064471 [TBL] [Abstract][Full Text] [Related]
3. LncRNA TTN-AS1 acts as sponge for miR-15b-5p to regulate FBXW7 expression in ovarian cancer. Miao S; Wang J; Xuan L; Liu X Biofactors; 2020 Jul; 46(4):600-607. PubMed ID: 32049388 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of Long Noncoding RNA FGD5-AS1 Ameliorates Myocardial Ischemia/Reperfusion Injury via MicroRNA-106a-5p and MicroRNA-106b-5p. Hao L; Wang J; Bi SJ; Cheng C J Cardiovasc Pharmacol; 2021 Jul; 78(1):e45-e54. PubMed ID: 34173804 [TBL] [Abstract][Full Text] [Related]
5. lncRNA Oip5-as1 attenuates myocardial ischaemia/reperfusion injury by sponging miR-29a to activate the SIRT1/AMPK/PGC1α pathway. Niu X; Pu S; Ling C; Xu J; Wang J; Sun S; Yao Y; Zhang Z Cell Prolif; 2020 Jun; 53(6):e12818. PubMed ID: 32468629 [TBL] [Abstract][Full Text] [Related]
6. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p. Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911 [TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA Xie F; Xie G; Sun Q Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747 [No Abstract] [Full Text] [Related]
8. LncRNA HIF1A-AS1 contributes to ventricular remodeling after myocardial ischemia/reperfusion injury by adsorption of microRNA-204 to regulating SOCS2 expression. Xue X; Luo L Cell Cycle; 2019 Oct; 18(19):2465-2480. PubMed ID: 31354024 [No Abstract] [Full Text] [Related]
9. LncRNA FOXD3-AS1 aggravates myocardial ischemia/reperfusion injury by inactivating the Redd1/AKT/GSK3β/Nrf2 signaling pathway via the miR-128/TXNIP axis. Chen B; Zheng L; Zhu T; Jiao K J Biochem Mol Toxicol; 2022 Dec; 36(12):e23218. PubMed ID: 36098178 [TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA Taurine-Upregulated Gene 1 Knockdown Protects Cardiomyocytes Against Hypoxia/Reoxygenation-induced Injury Through Regulating miR-532-5p/Sox8 Axis. Cai X; Wang S; Hong L; Yu S; Li B; Zeng H; Yang X; Zhang P; Shao L J Cardiovasc Pharmacol; 2020 Nov; 76(5):556-563. PubMed ID: 32833900 [TBL] [Abstract][Full Text] [Related]
12. Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR-513c-5p/PLK4 axis. Jia P; Wei E; Liu H; Wu T; Wang H IUBMB Life; 2020 Dec; 72(12):2627-2636. PubMed ID: 33031637 [TBL] [Abstract][Full Text] [Related]
13. Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis. Liu X; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X; Meng Y Cancer Gene Ther; 2021 May; 28(5):486-501. PubMed ID: 33277615 [TBL] [Abstract][Full Text] [Related]
14. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis. Zhao X; Wang J; Zhu R; Zhang J; Zhang Y Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393 [TBL] [Abstract][Full Text] [Related]
15. Protective effect of DLX6-AS1 silencing against cerebral ischemia/reperfusion induced impairments. Hu X; Xiang Z; Zhang W; Yu Z; Xin X; Zhang R; Deng Y; Yuan Q Aging (Albany NY); 2020 Nov; 12(22):23096-23113. PubMed ID: 33216728 [TBL] [Abstract][Full Text] [Related]
16. LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson's disease by regulating the miR-223-3p/NRP1 axis. Liu L; Zhou T; Li T; Liang Z; Luo X Behav Brain Res; 2022 Aug; 431():113923. PubMed ID: 35550840 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of LncRNA DLX6-AS1 inhibits HK-2 cell pyroptosis via regulating miR-223-3p/NLRP3 pathway in lipopolysaccharide-induced acute kidney injury. Tan J; Fan J; He J; Zhao L; Tang H J Bioenerg Biomembr; 2020 Oct; 52(5):367-376. PubMed ID: 32666494 [TBL] [Abstract][Full Text] [Related]
18. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis. Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p. Li D; Tang X; Li M; Zheng Y J Cell Biochem; 2019 Aug; 120(8):12290-12299. PubMed ID: 30805988 [TBL] [Abstract][Full Text] [Related]
20. DLX6-AS1 accelerates cell proliferation through regulating miR-497-5p/SNCG pathway in prostate cancer. Zhu X; Ma X; Zhao S; Cao Z Environ Toxicol; 2021 Mar; 36(3):308-319. PubMed ID: 33035382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]